Theriva Biologics Current Assets

Theriva Biologics (SYN) currently reports a current assets of $17M as of March 2026. That compares with $12M in the prior-year period — up 34.3% year over year. Use the charts on this page to explore Theriva Biologics's current assets history and peer comparisons.

Theriva Biologics's current assets increased from $12M to $17M — a 34.3% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Theriva Biologics reported $17M in current assets as of March 2026. That compares with $12M in the prior-year period — up 34.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $17M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Theriva Biologics, and consider following SYN for alerts when major investors trade the stock.

Theriva Biologics is classified in the Healthcare sector. On current assets, it currently shows $17M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SYN with unrelated industries.